Diagnostic value of the correlation between urinary MDM2 and podocyte mitotic catastrophe in diabetic kidney disease
Open Access
- 16 July 2025
- journal article
- research article
- Published by Springer Nature in Diabetology & Metabolic Syndrome
- Vol. 17 (1) , 1-12
Abstract
Podocytic injury and shedding are critical events in the progression and prognosis of diabetic nephropathy (DN). The purpose of our study was to observe heterokaryotic podocytes caused by mitotic catastrophe and the levels of murine double minute gene 2 (MDM2) and synaptopodin (SP) in the urine of patients with diabetic kidney disease (DKD) to explore their value as markers in the early diagnosis of DKD. We examined urine samples from diabetic patients, determined the presence of urinary podocytes and podocyte mitosis catastrophe (PMC), and analyzed their correlations with numerous indicators. Podocytes in urine sediment were observed and counted using immunofluorescence (IF), and the expression of MDM2 and SP in urine supernatant was detected using enzyme-linked immunosorbent assay (ELISA) kits. Podocytes might have been damaged in diabetic patients even during the period of normal albuminuria. Urinary SP level was positively correlated with urinary and heterolytic podocyte counts. MDM2 upregulation in urine was consistent with an increase in albuminuria level and heterolytic podocyte count. The sensitivity of urinary MDM2 to creatine (MDM2/Cr) in the diagnosis of DKD was high, as was the specificity of urinary SP to creatinine (SP/Cr). The diagnostic efficacy of combined urinary MDM2/Cr and SP/Cr was higher than that of either one alone. We observed that PMC and elevated urinary MDM2/Cr levels emerged early in DKD. Additionally, we developed a diagnostic panel combining urinary MDM2/Cr and SP/Cr, which might serve as a predictive tool for early DKD diagnosis and prevention. Urinary podocytes with abnormal nuclear morphology can be detected in the early stages of diabetic kidney disease. Urinary SP/Cr and MDM2/Cr can indicate the development and progression of DM. SP/Cr and MDM2/Cr serve as combined diagnostic biomarkers for early-stage diabetic kidney disease.Keywords
Funding Information
- The National Natural Science Foundation of China (No.81800642, 81770724)
- China Postdoctoral Science Foundation (2021M703608)
- Doctoral Scientific Research Foundation of Liaoning Province (20180540113)
This publication has 50 references indexed in Scilit:
- Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetesPediatric Nephrology, 2023
- Modes of podocyte death in diabetic kidney disease: an updateJournal Of Nephrology, 2022
- Nephron mass determines the excretion rate of urinary extracellular vesiclesJournal of Extracellular Vesicles, 2022
- Urinary podocyte markers in kidney diseasesClinica Chimica Acta, 2021
- Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and managementActa Pharmaceutica Sinica B, 2021
- Factors influencing blood pressure and microalbuminuria in children with type 1 diabetes mellitus: salt or sugar?Pediatric Nephrology, 2020
- Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human DiabeticsThe American Journal of Pathology, 2019
- PodocytesThe American Journal of Pathology, 2018
- Stress-Activated NRF2-MDM2 Cascade Controls Neoplastic Progression in PancreasCancer Cell, 2017
- Podocyte loss involves MDM2‐driven mitotic catastropheThe Journal of Pathology, 2013